Oncotarget: A New Class of Radiosensitizers for Glioblastoma

(50)

AI's Role in Advancing Intratumoral Immunotherapy | Oncotarget

(1:43)

The Nuclear Envelope and Metastasis | Oncotarget

(1:4)

Oncotarget: A New Potential Network of Biomarkers Useful Across Sarcomas

(49)

Breakthroughs in Cell-Penetrating Monoclonal Antibody Therapies | Oncotarget

(1:38)

Oncotarget: A Research Perspective on Hypofractionation

(49)

Tracking cfDNA Release Dynamics During Colorectal Cancer Surgery | Oncotarget

(3:)

Melatonin and Carcinogenesis in Mice: 50th Anniversary of Relationships | Oncotarget

(58)

Oncotarget: Therapeutic strategy for drug-resistant thyroid cancers

(7:35)

Metabolic Management of Glioblastoma | Thomas Seyfried, PhD

(43:11)

Behind the Study: Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167 | Oncotarget

(6:47)

HER3: A Vital Target in Cancer Treatment | Oncotarget

(8:49)

Nuclear deformability and telomere dynamics are regulated by cell geometric constraints

(1:26)

An Overview of Noble Metal-Based Nanoparticles in Medicine

(2:11)

Oncotarget: Novel insights into the prognostic evaluation of prostate cancer

(29:15)

The octahedral molybdenum clusters radiosensitizers against cancer.

(2:58)

Case for Inflammatory Memory for Hematopoietic Stem and Progenitor Cells in AML Niche | Oncotarget

(1:46)

Response of BRAF-Mutated Spindle Cell Sarcoma to BRAF/MEK Inhibitors | Oncotarget

(2:42)

Genomics Has More to Reveal | Oncotarget

(1:27)

HER2-Low Breast Cancer: Genomic Insights and Evolving Treatment Paradigms | Oncotarget

(1:30)

Oncotarget: A procaspase-3 activator and temozolomide extends survival in glioma models

(6:44)

Navigating Bias in AI-Driven Cancer Detection | Oncotarget

(1:31)

Enhancing DNA Damage and Immunotherapy by Starving Cancer Cells | Oncotarget

(1:36)

Generative AI in Cancer Imaging: Revolutionizing Detection \u0026 Diagnosis | Oncotarget

(1:6)

Tumor Dormancy Initiated by Lymphovascular Embolus | Oncotarget

(2:2)

Zika Virus as a Treatment for Brain Cancer: A Systematic Review | Oncotarget

(2:34)

Oncotarget: A chance for targeting cancer stem cells in human non-small cell lung cancer?

(6:55)

Next-Gen Cell-Penetrating Antibodies for Tumor Targeting and RAD51 Inhibition | Oncotarget

(1:30)

Immunotherapy Success in KRAS G12C Adenosquamous Pancreatic Cancer | Oncotarget

(1:45)